Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Sep:286:198073.
doi: 10.1016/j.virusres.2020.198073. Epub 2020 Jun 24.

Antiviral mechanisms of candidate chemical medicines and traditional Chinese medicines for SARS-CoV-2 infection

Chang Li  1 , Lin Wang  2 , Linzhu Ren  3
Affiliations
Review

Antiviral mechanisms of candidate chemical medicines and traditional Chinese medicines for SARS-CoV-2 infection

Chang Li et al. Virus Res. 2020 Sep.

Abstract

The Coronavirus Disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has rapidly become a global pandemic. Up to now, numerous medicines have been applied or approved for the prevention and control of the virus infection. However, the efficiency of each medicine or combination is completely different or still unknown. In this review, we discuss the types, characteristics, antiviral mechanisms, and shortcomings of recommended candidate medicines for SARS-CoV-2 infection, as well as perspectives of the drugs for the disease treatment, which may provide a theoretical basis for drug screening and application.

Keywords: Antiviral; Coronavirus disease 2019 (COVID-19); Medicine; Severe acute respiratory syndrome coronavirus 2 (2019 novel coronavirus, SARS-CoV-2).

PubMed Disclaimer

Conflict of interest statement

The author declares no conflict of interest. All authors have approved the final version of the manuscript.

References

    1. Adamsick M.L., Gandhi R.G., Bidell M.R., Elshaboury R.H., Bhattacharyya R.P., Kim A.Y., Nigwekar S., Rhee E.P., Sise M.E. Remdesivir in patients with acute or chronic kidney disease and COVID-19. J. Am. Soc. Nephrol. 2020;31(6) ASN.2020050589. - PMC - PubMed
    1. Adhikari S.P., Meng S., Wu Y.J., Mao Y.P., Ye R.X., Wang Q.Z., Sun C., Sylvia S., Rozelle S., Raat H., Zhou H. Epidemiology, causes, clinical manifestation and diagnosis, prevention and control of coronavirus disease (COVID-19) during the early outbreak period: a scoping review. Infect. Dis. Poverty. 2020;9(1):29. - PMC - PubMed
    1. Al-Tawfiq J.A., Al-Homoud A.H., Memish Z.A. Remdesivir as a possible therapeutic option for the COVID-19. Travel Med. Infect. Dis. 2020;34 - PMC - PubMed
    1. Amirian E.S., Levy J.K. Current knowledge about the antivirals remdesivir (GS-5734) and GS-441524 as therapeutic options for coronaviruses. One Health. 2020;9 - PMC - PubMed
    1. Ang L., Lee H.W., Choi J.Y., Zhang J., Soo Lee M. Herbal medicine and pattern identification for treating COVID-19: a rapid review of guidelines. Integr. Med. Res. 2020;9(2) - PMC - PubMed

Publication types

MeSH terms

LinkOut - more resources